Company
United StatesPublic company, NASDAQ: LINLinde Inc (NASDAQ: LIN), Wilmington, NC – FDA Inspections
Inspection records and compliance data for Linde Inc in Wilmington, North Carolina. 1 FDA inspection on record, last inspected April 20, 2018. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc based in Wilmington, North Carolina, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected April 20, 2018.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 20, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1058501 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1050539
Address
4832 Us Highway 421 N, Wilmington, North Carolina 28401, United States
Country
United States
ID: a4799f55-6d58-4447-9b84-74479fc74e36